Dexmedetomidine Use and Reduced In-hospital Mortality in ICU Patients with Delirium: A Retrospective Study Based on Two Observational Cohorts
< 0.0001). Propensity score analyses confirmed these findings. Furthermore, mortality at 90 days, 180 days, and 1 year was also significantly reduced in the dexmedetomidine group.ConclusionsDexmedetomidine administration during ICU stay correlates with a reduced mortality risk in critically ill patients suffering from delirium.
Authors
- Sai Zhou
- 刘惠萍
- WENMING SONG
- Huan Chang (ORCID: https://orcid.org/0009-0005-8908-5761)
- Gong Chen (ORCID: https://orcid.org/0009-0002-6232-2331)
- Lizhi Fu
Institutions
- Central South University (CN)
- Changsha Medical University (CN)
- The First People's Hospital of Changde (CN)
- Third Xiangya Hospital (CN)
Publication Details
- Journal
- Journal of Intensive Care Medicine
- Published
- 2026-04-15
- DOI
- https://doi.org/10.1177/08850666261440805
- Primary Topic
- Intensive Care Unit Cognitive Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00